Tepotinib in patients ( pts) with MET exon 14 (METex14) skipping non-small cell lung cancer (NSCLC) from the VISION study: ≥3-year follow-up outcomes

  • Mazieres, Julien
  • Veillon, R.
  • Cortot, A.
  • Ferrara, R.
  • Felip, E.
  • 외 15명
Citations

WEB OF SCIENCE

1
제목
Tepotinib in patients ( pts) with MET exon 14 (METex14) skipping non-small cell lung cancer (NSCLC) from the VISION study: ≥3-year follow-up outcomes
저자
Mazieres, JulienVeillon, R.Cortot, A.Ferrara, R.Felip, E.Garassino, M.Le, X.Thomas, M.Sakai, H.Smit, E.Raskin, J.Viteri, S.Yang, J. c-h.Ahn, M-JWu, Y-LZhao, J.Ghori, V.Bruns, R.Johne, A.Paik, P.
발행일
2025-03
유형
Meeting Abstract
저널명
Journal of Thoracic Oncology
20
3
페이지
S59 ~ S60